Seminoma; Embryonal carcinoma; DNA DSBs; Homologous recombination; PARP inhibitors; Deferoxamine; Ferrostatin-1; xCT/SLC7A11 cystine antiporter; Erastin; Targeted therapies; Glutathione. Here, SLC7A11 is linked to embryonal carcinoma.